Flowserve Corporation Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Flowserve Corporation Common Stock trades at $70.6 (market cap $8.96B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 6.5× Flowserve Corporation Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.36%). Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| FLS | TAK | |
|---|---|---|
Market Cap | $8.96B | $58.16B |
Volume | 1,946,178 | 2,467,530 |
Sector | Industrials | Health |
52-Week High | $92.04 | $19.05 |
52-Week Low | $49.09 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.55B | $86.04B |
Dividend Yield | 1.25% | 3.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →